至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Identification of a human respiratory syncytial virus phosphoprotein domain required for virus-like-particle formation.

Virology. 2019; 
Meshram CD, Oomens AGP.
Products/Services Used Details Operation
Peptide Synthesis … Mab19 (anti-F) was provided by Ed Walsh (University of Rochester School of Medicine). Anti-flag antibody was acquired from Genscript. A rabbit polyclonal anti-M peptide serum was reported previously (Mitra et al., 2012). Plasmid constructs for transfection … Get A Quote

摘要

Perceived inefficiency and inadequate knowledge of the human respiratory syncytial virus (hRSV) assembly process present a hurdle for large-scale production of authentic hRSV virus-like particles (VLPs) for vaccine purposes. We previously established that the matrix protein, phosphoprotein (P), and fusion protein carboxy-terminus were sufficient to generate VLPs that resemble filamentous wildtype hRSV. Here, the contribution of P was examined. By co-expressing matrix, fusion, and modified P proteins, a ser/thr-rich P region (residues 39-57) was found to be critical for VLP formation, whereas the oligomerization domain was not. Substitutions throughout region 39-57 inhibited VLP formation and relevant amino acid... More

关键词

Assembly; Phosphoprotein; Respiratory syncytial virus; Virus-like-particle